Intravacc Awarded US$14.6 Million NIH/NIAID Contract to Develop Intranasal Gonorrhea Vaccine ...Middle East

Gonorrhea is on the WHO high-priority list of antimicrobial resistant bacteria World's first intranasal prophylactic gonorrhea vaccine candidate Mucosal vaccine platforms provides a broad opportunity for viral and bacterial vaccines BILTHOVEN, The Netherlands, Oct. 5, 2022 /PRNewswire/ --...

Hence then, the article about intravacc awarded us 14 6 million nih niaid contract to develop intranasal gonorrhea vaccine was published today ( Wednesday 05/10/2022 - 09:13 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Intravacc Awarded US$14.6 Million NIH/NIAID Contract to Develop Intranasal Gonorrhea Vaccine )

Also on site :

• Saks Global Secures $1.75 Billion of Committed Capital and Announces Return of Industry Veterans to Advance Transformation of Iconic Luxury Portfolio
• Another Weight Loss Surgery and a Wedding Bombshell: Spoilers From '1000-Lb Sisters' Season 8 Episode 2
• Trump-Iran latest: President threatens ‘very strong action’ if protesters are hanged after forced confessions